Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
department of health and human services
drug prices
regeneron pharmaceuticals
scott gottlieb
alex azar
alirocumab
alnylam pharmaceuticals
ambys medicines
american patients first
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
What
drugs
long
3
×
awaited
drug
house
plan
prices
trump
unveiled
white
administration
afternoon
anticipated
aren’t
bio
blueprint
canada
canadian
cheaper
cost
costly
countries
cut
department
details
developers
excludes
fda
floats
gene
health
help
imminent
import
lower
meant
medicare
medications
moves
news
Language
unknown
Current search:
national
×
fda
×
long
×
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
